<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2023</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>15</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>37034889</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Is Formulary of Maranta Arundinacea Clarias Gariepinus (F-MaCg) a Potential Immunostimulant?</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background: E&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;xternal factors have the potential to act as immunostimulants in order to influence the body&amp;#39;s protection from many foreign antigens. We intended to investigate the ethanol extract Formulary of F-MaCg effect as an immunostimulant.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;nbsp;A purely experimental with a completely randomized design was used on twenty-four white male rats. They were divided into four groups:1) G0 [given aquades (5 &lt;em&gt;ml&lt;/em&gt;)]; 2) G1 [given F-MaCg-75 &lt;em&gt;mg/gr&lt;/em&gt; BW (Body Weight)]; 3) G2 (F-MaCg -150 &lt;em&gt;mg/gr&lt;/em&gt; plus Hepatitis B vaccine at the beginning and the end of treatment); and 4) G3 (F-MaCg -300 &lt;em&gt;mg/gr&lt;/em&gt; BW plus hepatitis B vaccine at the end of treatment). The rat&amp;#39;s spleen lymphocyte blast transformation was evaluated on the 15th and 37th days. Lymphocytes were examined using microtetrazolium assays. Optical Density (OD) was measured using an ELISA reader [493 &lt;em&gt;n&lt;span style=&quot;background-color:white&quot;&gt;&amp;mu;&lt;/span&gt;&lt;/em&gt; (nanomicro)]. Observation of lymphocyte viability by a counting chamber using a light microscope and trypan blue 1 % before being cultured with Phytohaemoaglutinin.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;nbsp;Lymphocyte cell viability in the hepatitis B vaccine-induced group on the 15th day showed the highest average value in the G2 (1,484/&lt;em&gt;mcl&lt;/em&gt; of blood); on the 37th day, it was in G3 (1,578/&lt;em&gt;mcl&lt;/em&gt; of blood). The proliferative activity of spleen lymphocytes indicated by the difference in the OD values of the four treatment groups was 0.467, 0.913, 1.619, and 1.473 &lt;em&gt;n&lt;span style=&quot;background-color:white&quot;&gt;&amp;mu;&lt;/span&gt;&lt;/em&gt;, respectively. Histological observations of the spleen showed differences at all given formulary dose concentrations.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&amp;nbsp;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;F-MaCg could be an immunostimulant because of its ability to trigger a cellular immune response.&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Adjuvant, Enzyme-linked immunosorbent assay, Immunologic, Lymphocyte activation, Lymphocytes, Male, Plant extracts, Rats</keyword>
	<start_page>91</start_page>
	<end_page>99</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=60535</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/60535.pdf</pdf_url>
	<author_list><author><first_name>Zulkifli</first_name><middle_name></middle_name><last_name>Zulkifli</last_name><suffix></suffix><affiliation>Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92008</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Darmawi</first_name><middle_name></middle_name><last_name>Darmawi</last_name><suffix></suffix><affiliation>Department of Veterinary Medicine, Faculty of Veterinary Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92010</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Said</first_name><middle_name></middle_name><last_name>Usman</last_name><suffix></suffix><affiliation>Department of Public Health, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92011</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Kurnia</first_name><middle_name></middle_name><last_name>Fitri Jamil </last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92009</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

